154 related articles for article (PubMed ID: 17549666)
1. Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma.
Stav D; Bar I; Sandbank J
Int J Biol Markers; 2007; 22(2):108-13. PubMed ID: 17549666
[TBL] [Abstract][Full Text] [Related]
2. Discrimination of human lung neoplasm from normal lung by two target genes.
Hofmann HS; Hansen G; Burdach S; Bartling B; Silber RE; Simm A
Am J Respir Crit Care Med; 2004 Sep; 170(5):516-9. PubMed ID: 15331390
[TBL] [Abstract][Full Text] [Related]
3. Gene expression analysis of lung adenocarcinoma and matched adjacent non-tumor lung tissue.
Zhang W; Gong W; Ai H; Tang J; Shen C
Tumori; 2014; 100(3):338-45. PubMed ID: 25076248
[TBL] [Abstract][Full Text] [Related]
4. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer.
Liu J; Lin Y; Yang H; Deng Q; Chen G; He J
Tumour Biol; 2011 Dec; 32(6):1113-21. PubMed ID: 21779982
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific expression profiling of receptor for advanced glycation end products and its soluble forms in esophageal and lung cancer.
Jing RR; Cui M; Sun BL; Yu J; Wang HM
Genet Test Mol Biomarkers; 2010 Jun; 14(3):355-61. PubMed ID: 20578941
[TBL] [Abstract][Full Text] [Related]
6. Lung adenocarcinoma expressing receptor for advanced glycation end-products with primary systemic AL amyloidosis: a case report and literature review.
Okamoto S; Togo S; Nagata I; Shimizu K; Koinuma Y; Namba Y; Ito J; Uekusa T; Takahashi K
BMC Cancer; 2017 Jan; 17(1):22. PubMed ID: 28056871
[TBL] [Abstract][Full Text] [Related]
7. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
[TBL] [Abstract][Full Text] [Related]
8. Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer.
Jing R; Cui M; Wang J; Wang H
Neoplasma; 2010; 57(1):55-61. PubMed ID: 19895173
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells.
Berrou J; Tostivint I; Verrecchia F; Berthier C; Boulanger E; Mauviel A; Marti HP; Wautier MP; Wautier JL; Rondeau E; Hertig A
Int J Mol Med; 2009 Apr; 23(4):513-20. PubMed ID: 19288028
[TBL] [Abstract][Full Text] [Related]
10. Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma.
Ishikawa M; Sonobe M; Imamura N; Sowa T; Shikuma K; Date H
World J Surg Oncol; 2014 Aug; 12():253. PubMed ID: 25103784
[TBL] [Abstract][Full Text] [Related]
11. CDK5RAP3 acts as a tumor suppressor in gastric cancer through inhibition of β-catenin signaling.
Wang JB; Wang ZW; Li Y; Huang CQ; Zheng CH; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Lin Y; Huang CM
Cancer Lett; 2017 Jan; 385():188-197. PubMed ID: 27793695
[TBL] [Abstract][Full Text] [Related]
12. CDK5RAP3 is a novel repressor of p14ARF in hepatocellular carcinoma cells.
Mak GW; Lai WL; Zhou Y; Li M; Ng IO; Ching YP
PLoS One; 2012; 7(7):e42210. PubMed ID: 22860085
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of immunogenic cell death biomarker rage and early growth response 1 in human primary gastric adenocarcinoma.
Xu XC; Gao H; Zhang WB; Abuduhadeer X; Wang YH
Int J Immunopathol Pharmacol; 2013; 26(2):485-93. PubMed ID: 23755764
[TBL] [Abstract][Full Text] [Related]
14. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes.
Amatschek S; Koenig U; Auer H; Steinlein P; Pacher M; Gruenfelder A; Dekan G; Vogl S; Kubista E; Heider KH; Stratowa C; Schreiber M; Sommergruber W
Cancer Res; 2004 Feb; 64(3):844-56. PubMed ID: 14871811
[TBL] [Abstract][Full Text] [Related]
15. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H
Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359
[TBL] [Abstract][Full Text] [Related]
16. CDK5RAP3 Participates in Autophagy Regulation and Is Downregulated in Renal Cancer.
Li J; Hu X; Su M; Shen H; Qiu W; Tian Y
Dis Markers; 2019; 2019():6171782. PubMed ID: 31061682
[TBL] [Abstract][Full Text] [Related]
17. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways.
Huttunen HJ; Fages C; Rauvala H
J Biol Chem; 1999 Jul; 274(28):19919-24. PubMed ID: 10391939
[TBL] [Abstract][Full Text] [Related]
18. Increased Expression of the Receptor for Advanced Glycation End-Products (RAGE) Is Associated with Advanced Breast Cancer Stage.
Nankali M; Karimi J; Goodarzi MT; Saidijam M; Khodadadi I; Razavi AN; Rahimi F
Oncol Res Treat; 2016; 39(10):622-628. PubMed ID: 27710974
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays.
Hsieh HL; Schäfer BW; Sasaki N; Heizmann CW
Biochem Biophys Res Commun; 2003 Jul; 307(2):375-81. PubMed ID: 12859967
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end-products and receptor for advanced glycation end-products expression in patients with idiopathic pulmonary fibrosis and NSIP.
Kyung SY; Byun KH; Yoon JY; Kim YJ; Lee SP; Park JW; Lee BH; Park JS; Jang AS; Park CS; Jeong SH
Int J Clin Exp Pathol; 2014; 7(1):221-8. PubMed ID: 24427342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]